BIOFRONTERA INC. COMMON STOCK PURCHASE WARRANTSecurity Agreement • July 28th, 2022 • Biofrontera Inc. • Pharmaceutical preparations
Contract Type FiledJuly 28th, 2022 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 27, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December 1, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Biofrontera Inc., a Delaware corporation (the “Company”), up to [___________] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).